Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Computational techniques can improve drug development for treating certain conditions.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Finasteride and dutasteride are equally effective and safe for treating BPH.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Personalized, minimally invasive treatments improve urology outcomes.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.